Medical Subject Headings

Home > Library Catalogs and Services > MeSH

MeSH Tree Structures - 2008

C18 - Nutritional and Metabolic Diseases

• Nutritional and Metabolic Diseases [C18]
  • Metabolic Diseases [C18.452]
    • Acid-Base Imbalance [C18.452.076]
      • Achlorhydria [C18.452.076.087]
      • Acidosis [C18.452.076.176]
        • Acidosis, Lactic [C18.452.076.176.180]
        • Acidosis, Renal Tubular [C18.452.076.176.210]
        • Acidosis, Respiratory [C18.452.076.176.310]
        • Diabetic Ketoacidosis [C18.452.076.176.390]
        • Ketosis [C18.452.076.176.652]
      • Alkalosis [C18.452.076.354]
        • Alkalosis, Respiratory [C18.452.076.354.271]
    • Amyloidosis [C18.452.090]
      • Amyloid Neuropathies [C18.452.090.050]
        • Amyloid Neuropathies, Familial [C18.452.090.050.050]
      • Amyloidosis, Familial [C18.452.090.075]
        • Amyloid Neuropathies, Familial [C18.452.090.075.050]
        • Cerebral Amyloid Angiopathy, Familial [C18.452.090.075.160]
      • Cerebral Amyloid Angiopathy [C18.452.090.100]
        • Cerebral Amyloid Angiopathy, Familial [C18.452.090.100.160]
    • Brain Diseases, Metabolic [C18.452.132]
      • Brain Diseases, Metabolic, Inborn [C18.452.132.100]
        • Carbamoyl-Phosphate Synthase I Deficiency Disease [C18.452.132.100.162]
        • Cerebral Amyloid Angiopathy, Familial [C18.452.132.100.168]
        • Citrullinemia [C18.452.132.100.175]
        • Galactosemias [C18.452.132.100.320]
        • Hartnup Disease [C18.452.132.100.355]
        • Hepatolenticular Degeneration [C18.452.132.100.360]
        • Homocystinuria [C18.452.132.100.365]
        • Hyperargininemia [C18.452.132.100.370]
        • Hyperglycinemia, Nonketotic [C18.452.132.100.375]
        • Hyperlysinemias [C18.452.132.100.380]
        • Leigh Disease [C18.452.132.100.412]
        • Lesch-Nyhan Syndrome [C18.452.132.100.425]
        • Lysosomal Storage Diseases, Nervous System [C18.452.132.100.435]
          • Fucosidosis [C18.452.132.100.435.295]
          • Glycogen Storage Disease Type II [C18.452.132.100.435.340]
          • Mucolipidoses [C18.452.132.100.435.590]
          • Sialic Acid Storage Disease [C18.452.132.100.435.810]
          • Sphingolipidoses [C18.452.132.100.435.825]
            • Fabry Disease [C18.452.132.100.435.825.200]
            • Gangliosidoses [C18.452.132.100.435.825.300]
              • Gangliosidoses, GM2 [C18.452.132.100.435.825.300.300]
                • Sandhoff Disease [C18.452.132.100.435.825.300.300.249]
                • Tay-Sachs Disease [C18.452.132.100.435.825.300.300.500]
                • Tay-Sachs Disease, AB Variant [C18.452.132.100.435.825.300.300.750]
              • Gangliosidosis, GM1 [C18.452.132.100.435.825.300.400]
              • Sandhoff Disease [C18.452.132.100.435.825.300.700]
            • Gaucher Disease [C18.452.132.100.435.825.400]
            • Leukodystrophy, Globoid Cell [C18.452.132.100.435.825.590]
            • Niemann-Pick Diseases [C18.452.132.100.435.825.700]
              • Niemann-Pick Disease, Type A [C18.452.132.100.435.825.700.500]
              • Niemann-Pick Disease, Type B [C18.452.132.100.435.825.700.750]
              • Niemann-Pick Disease, Type C [C18.452.132.100.435.825.700.875]
            • Sea-Blue Histiocyte Syndrome [C18.452.132.100.435.825.775]
            • Sulfatidosis [C18.452.132.100.435.825.850]
              • Leukodystrophy, Metachromatic [C18.452.132.100.435.825.850.500]
              • Multiple Sulfatase Deficiency Disease [C18.452.132.100.435.825.850.750]
        • Maple Syrup Urine Disease [C18.452.132.100.520]
        • MELAS Syndrome [C18.452.132.100.535]
        • Menkes Kinky Hair Syndrome [C18.452.132.100.540]
        • MERRF Syndrome [C18.452.132.100.545]
        • Oculocerebrorenal Syndrome [C18.452.132.100.640]
        • Ornithine Carbamoyltransferase Deficiency Disease [C18.452.132.100.650]
        • Peroxisomal Disorders [C18.452.132.100.680]
          • Adrenoleukodystrophy [C18.452.132.100.680.100]
          • Mevalonate Kinase Deficiency [C18.452.132.100.680.430]
          • Refsum Disease [C18.452.132.100.680.760]
          • Refsum Disease, Infantile [C18.452.132.100.680.865]
          • Zellweger Syndrome [C18.452.132.100.680.970]
        • Phenylketonurias [C18.452.132.100.687]
          • Phenylketonuria, Maternal [C18.452.132.100.687.500]
        • Pyruvate Carboxylase Deficiency Disease [C18.452.132.100.725]
        • Pyruvate Dehydrogenase Complex Deficiency Disease [C18.452.132.100.750]
        • Tyrosinemias [C18.452.132.100.875]
      • Hepatic Encephalopathy [C18.452.132.360]
      • Kernicterus [C18.452.132.480]
      • Mitochondrial Encephalomyopathies [C18.452.132.540]
      • Myelinolysis, Central Pontine [C18.452.132.560]
      • Reye Syndrome [C18.452.132.780]
      • Wernicke Encephalopathy [C18.452.132.960]
    • Calcium Metabolism Disorders [C18.452.174]
      • Calcinosis [C18.452.174.130]
        • Calciphylaxis [C18.452.174.130.186]
        • CREST Syndrome [C18.452.174.130.204]
        • Nephrocalcinosis [C18.452.174.130.560]
      • Decalcification, Pathologic [C18.452.174.289]
      • Hypercalcemia [C18.452.174.451]
      • Hypocalcemia [C18.452.174.509]
        • Tetany [C18.452.174.509.700]
      • Osteomalacia [C18.452.174.662]
      • Pseudohypoparathyroidism [C18.452.174.766]
        • Pseudopseudohypoparathyroidism [C18.452.174.766.815]
      • Rickets [C18.452.174.845]
        • Hypophosphatemic Rickets, X-Linked Dominant [C18.452.174.845.500]
        • Renal Osteodystrophy [C18.452.174.845.750]
    • DNA Repair-Deficiency Disorders [C18.452.284]
      • Ataxia Telangiectasia [C18.452.284.060]
      • Bloom Syndrome [C18.452.284.100]
      • Cockayne Syndrome [C18.452.284.250]
      • Colorectal Neoplasms, Hereditary Nonpolyposis [C18.452.284.255]
      • Fanconi Anemia [C18.452.284.280]
      • Li-Fraumeni Syndrome [C18.452.284.520]
      • Nijmegen Breakage Syndrome [C18.452.284.600]
      • Rothmund-Thomson Syndrome [C18.452.284.760]
      • Severe Combined Immunodeficiency [C18.452.284.800]
      • Werner Syndrome [C18.452.284.960]
      • Xeroderma Pigmentosum [C18.452.284.975]
    • Glucose Metabolism Disorders [C18.452.394]
      • Diabetes Mellitus [C18.452.394.750]
        • Diabetes Mellitus, Experimental [C18.452.394.750.074]
        • Diabetes Mellitus, Type 1 [C18.452.394.750.124]
          • Wolfram Syndrome [C18.452.394.750.124.960]
        • Diabetes Mellitus, Type 2 [C18.452.394.750.149]
          • Diabetes Mellitus, Lipoatrophic [C18.452.394.750.149.500]
        • Diabetes, Gestational [C18.452.394.750.448]
        • Diabetic Ketoacidosis [C18.452.394.750.535]
        • Prediabetic State [C18.452.394.750.774]
      • Glycosuria [C18.452.394.937]
        • Glycosuria, Renal [C18.452.394.937.450]
      • Hyperglycemia [C18.452.394.952]
        • Glucose Intolerance [C18.452.394.952.500]
      • Hyperinsulinism [C18.452.394.968]
        • Insulin Resistance [C18.452.394.968.500]
          • Metabolic Syndrome X [C18.452.394.968.500.570]
        • Persistent Hyperinsulinemia Hypoglycemia of Infancy [C18.452.394.968.750]
      • Hypoglycemia [C18.452.394.984]
        • Insulin Coma [C18.452.394.984.492]
        • Persistent Hyperinsulinemia Hypoglycemia of Infancy [C18.452.394.984.746]
    • Iron Metabolism Disorders [C18.452.565]
      • Anemia, Iron-Deficiency [C18.452.565.100]
      • Iron Overload [C18.452.565.500]
        • Hemochromatosis [C18.452.565.500.480]
        • Hemosiderosis [C18.452.565.500.500]
    • Lipid Metabolism Disorders [C18.452.584]
      • Dyslipidemias [C18.452.584.500]
        • Hyperlipidemias [C18.452.584.500.500]
          • Hypercholesterolemia [C18.452.584.500.500.396]
          • Hyperlipidemia, Familial Combined [C18.452.584.500.500.438]
          • Hyperlipoproteinemias [C18.452.584.500.500.644]
            • Hyperlipoproteinemia Type I [C18.452.584.500.500.644.237]
            • Hyperlipoproteinemia Type II [C18.452.584.500.500.644.475]
            • Hyperlipoproteinemia Type III [C18.452.584.500.500.644.485]
            • Hyperlipoproteinemia Type IV [C18.452.584.500.500.644.490]
            • Hyperlipoproteinemia Type V [C18.452.584.500.500.644.495]
          • Hypertriglyceridemia [C18.452.584.500.500.851]
            • Hyperlipoproteinemia Type IV [C18.452.584.500.500.851.500]
        • Hypolipoproteinemias [C18.452.584.500.875]
          • Hypoalphalipoproteinemias [C18.452.584.500.875.330]
            • Lecithin Acyltransferase Deficiency [C18.452.584.500.875.330.500]
            • Tangier Disease [C18.452.584.500.875.330.750]
          • Hypobetalipoproteinemias [C18.452.584.500.875.440]
            • Abetalipoproteinemia [C18.452.584.500.875.440.500]
            • Hypobetalipoproteinemia, Familial, Apolipoprotein B [C18.452.584.500.875.440.750]
        • Smith-Lemli-Opitz Syndrome [C18.452.584.500.937]
      • Lipid Metabolism, Inborn Errors [C18.452.584.562]
      • Lipodystrophy [C18.452.584.625]
        • HIV-Associated Lipodystrophy Syndrome [C18.452.584.625.400]
        • Lipodystrophy, Congenital Generalized [C18.452.584.625.550]
        • Lipodystrophy, Familial Partial [C18.452.584.625.700]
      • Lipidoses [C18.452.584.687]
        • Cholesterol Ester Storage Disease [C18.452.584.687.201]
          • Wolman Disease [C18.452.584.687.201.500]
        • Neuronal Ceroid-Lipofuscinoses [C18.452.584.687.509]
        • Sjogren-Larsson Syndrome [C18.452.584.687.723]
        • Sphingolipidoses [C18.452.584.687.803]
          • Fabry Disease [C18.452.584.687.803.300]
          • Gangliosidoses [C18.452.584.687.803.350]
            • Gangliosidoses, GM2 [C18.452.584.687.803.350.300]
              • Sandhoff Disease [C18.452.584.687.803.350.300.700]
              • Tay-Sachs Disease [C18.452.584.687.803.350.300.850]
              • Tay-Sachs Disease, AB Variant [C18.452.584.687.803.350.300.925]
            • Gangliosidosis, GM1 [C18.452.584.687.803.350.360]
          • Gaucher Disease [C18.452.584.687.803.441]
          • Leukodystrophy, Globoid Cell [C18.452.584.687.803.585]
          • Niemann-Pick Diseases [C18.452.584.687.803.730]
            • Niemann-Pick Disease, Type A [C18.452.584.687.803.730.500]
            • Niemann-Pick Disease, Type B [C18.452.584.687.803.730.750]
            • Niemann-Pick Disease, Type C [C18.452.584.687.803.730.875]
          • Sea-Blue Histiocyte Syndrome [C18.452.584.687.803.850]
          • Sulfatidosis [C18.452.584.687.803.925]
            • Leukodystrophy, Metachromatic [C18.452.584.687.803.925.500]
            • Multiple Sulfatase Deficiency Disease [C18.452.584.687.803.925.750]
      • Lipomatosis [C18.452.584.718]
        • Adiposis Dolorosa [C18.452.584.718.500]
        • Lipomatosis, Multiple Symmetrical [C18.452.584.718.750]
      • Xanthomatosis [C18.452.584.750]
        • Xanthomatosis, Cerebrotendinous [C18.452.584.750.975]
    • Malabsorption Syndromes [C18.452.603]
      • Blind Loop Syndrome [C18.452.603.145]
      • Celiac Disease [C18.452.603.250]
      • Lactose Intolerance [C18.452.603.506]
      • Sprue, Tropical [C18.452.603.850]
      • Steatorrhea [C18.452.603.887]
      • Whipple Disease [C18.452.603.925]
    • Metabolic Syndrome X [C18.452.625]
    • Metabolism, Inborn Errors [C18.452.648]
      • Amino Acid Metabolism, Inborn Errors [C18.452.648.100]
        • Albinism [C18.452.648.100.102]
          • Albinism, Ocular [C18.452.648.100.102.090]
          • Albinism, Oculocutaneous [C18.452.648.100.102.100]
            • Hermanski-Pudlak Syndrome [C18.452.648.100.102.100.400]
          • Piebaldism [C18.452.648.100.102.600]
        • Alkaptonuria [C18.452.648.100.187]
        • Carbamoyl-Phosphate Synthase I Deficiency Disease [C18.452.648.100.275]
        • Citrullinemia [C18.452.648.100.340]
        • Homocystinuria [C18.452.648.100.470]
        • Hyperargininemia [C18.452.648.100.475]
        • Hyperglycinemia, Nonketotic [C18.452.648.100.477]
        • Hyperhomocysteinemia [C18.452.648.100.480]
        • Hyperlysinemias [C18.452.648.100.544]
        • Maple Syrup Urine Disease [C18.452.648.100.608]
        • Multiple Acyl Coenzyme A Dehydrogenase Deficiency [C18.452.648.100.614]
        • Multiple Carboxylase Deficiency [C18.452.648.100.620]
          • Biotinidase Deficiency [C18.452.648.100.620.100]
          • Holocarboxylase Synthetase Deficiency [C18.452.648.100.620.380]
        • Ornithine Carbamoyltransferase Deficiency Disease [C18.452.648.100.729]
        • Phenylketonurias [C18.452.648.100.766]
          • Phenylketonuria, Maternal [C18.452.648.100.766.500]
        • Tyrosinemias [C18.452.648.100.880]
      • Amino Acid Transport Disorders, Inborn [C18.452.648.151]
        • Hartnup Disease [C18.452.648.151.355]
        • Oculocerebrorenal Syndrome [C18.452.648.151.600]
      • Amyloidosis, Familial [C18.452.648.176]
        • Amyloid Neuropathies, Familial [C18.452.648.176.050]
        • Cerebral Amyloid Angiopathy, Familial [C18.452.648.176.160]
      • Brain Diseases, Metabolic, Inborn [C18.452.648.189]
        • Carbamoyl-Phosphate Synthase I Deficiency Disease [C18.452.648.189.162]
        • Cerebral Amyloid Angiopathy, Familial [C18.452.648.189.168]
        • Citrullinemia [C18.452.648.189.175]
        • Galactosemias [C18.452.648.189.320]
        • Hartnup Disease [C18.452.648.189.355]
        • Hepatolenticular Degeneration [C18.452.648.189.360]
        • Homocystinuria [C18.452.648.189.365]
        • Hyperargininemia [C18.452.648.189.370]
        • Hyperglycinemia, Nonketotic [C18.452.648.189.375]
        • Hyperlysinemias [C18.452.648.189.380]
        • Leigh Disease [C18.452.648.189.412]
        • Lesch-Nyhan Syndrome [C18.452.648.189.425]
        • Lysosomal Storage Diseases, Nervous System [C18.452.648.189.435]
          • Fucosidosis [C18.452.648.189.435.295]
          • Glycogen Storage Disease Type II [C18.452.648.189.435.340]
          • Mucolipidoses [C18.452.648.189.435.590]
          • Sialic Acid Storage Disease [C18.452.648.189.435.810]
          • Sphingolipidoses [C18.452.648.189.435.825]
            • Fabry Disease [C18.452.648.189.435.825.200]
            • Gangliosidoses [C18.452.648.189.435.825.300]
              • Gangliosidoses, GM2 [C18.452.648.189.435.825.300.300]
                • Sandhoff Disease [C18.452.648.189.435.825.300.300.249]
                • Tay-Sachs Disease [C18.452.648.189.435.825.300.300.500]
                • Tay-Sachs Disease, AB Variant [C18.452.648.189.435.825.300.300.750]
              • Gangliosidosis, GM1 [C18.452.648.189.435.825.300.400]
              • Sandhoff Disease [C18.452.648.189.435.825.300.700]
            • Gaucher Disease [C18.452.648.189.435.825.400]
            • Leukodystrophy, Globoid Cell [C18.452.648.189.435.825.590]
            • Niemann-Pick Diseases [C18.452.648.189.435.825.700]
              • Niemann-Pick Disease, Type A [C18.452.648.189.435.825.700.500]
              • Niemann-Pick Disease, Type B [C18.452.648.189.435.825.700.750]
              • Niemann-Pick Disease, Type C [C18.452.648.189.435.825.700.875]
            • Sea-Blue Histiocyte Syndrome [C18.452.648.189.435.825.775]
            • Sulfatidosis [C18.452.648.189.435.825.850]
              • Leukodystrophy, Metachromatic [C18.452.648.189.435.825.850.500]
              • Multiple Sulfatase Deficiency Disease [C18.452.648.189.435.825.850.750]
        • Maple Syrup Urine Disease [C18.452.648.189.520]
        • MELAS Syndrome [C18.452.648.189.535]
        • Menkes Kinky Hair Syndrome [C18.452.648.189.540]
        • MERRF Syndrome [C18.452.648.189.545]
        • Oculocerebrorenal Syndrome [C18.452.648.189.640]
        • Ornithine Carbamoyltransferase Deficiency Disease [C18.452.648.189.650]
        • Peroxisomal Disorders [C18.452.648.189.680]
          • Adrenoleukodystrophy [C18.452.648.189.680.100]
          • Mevalonate Kinase Deficiency [C18.452.648.189.680.430]
          • Refsum Disease [C18.452.648.189.680.760]
          • Refsum Disease, Infantile [C18.452.648.189.680.865]
          • Zellweger Syndrome [C18.452.648.189.680.970]
        • Phenylketonurias [C18.452.648.189.687]
          • Phenylketonuria, Maternal [C18.452.648.189.687.500]
        • Pyruvate Carboxylase Deficiency Disease [C18.452.648.189.725]
        • Pyruvate Dehydrogenase Complex Deficiency Disease [C18.452.648.189.750]
        • Tyrosinemias [C18.452.648.189.875]
      • Carbohydrate Metabolism, Inborn Errors [C18.452.648.202]
        • Carbohydrate-Deficient Glycoprotein Syndrome [C18.452.648.202.125]
        • Fructose Metabolism, Inborn Errors [C18.452.648.202.251]
          • Fructose-1,6-Diphosphatase Deficiency [C18.452.648.202.251.221]
          • Fructose Intolerance [C18.452.648.202.251.271]
        • Fucosidosis [C18.452.648.202.303]
        • Galactosemias [C18.452.648.202.355]
        • Glucosephosphate Dehydrogenase Deficiency [C18.452.648.202.402]
        • Glycogen Storage Disease [C18.452.648.202.449]
          • Glycogen Storage Disease Type I [C18.452.648.202.449.448]
          • Glycogen Storage Disease Type II [C18.452.648.202.449.500]
          • Glycogen Storage Disease Type IIb [C18.452.648.202.449.510]
          • Glycogen Storage Disease Type III [C18.452.648.202.449.520]
          • Glycogen Storage Disease Type IV [C18.452.648.202.449.540]
          • Glycogen Storage Disease Type V [C18.452.648.202.449.560]
          • Glycogen Storage Disease Type VI [C18.452.648.202.449.580]
          • Glycogen Storage Disease Type VII [C18.452.648.202.449.600]
          • Glycogen Storage Disease Type VIII [C18.452.648.202.449.620]
        • Hyperoxaluria, Primary [C18.452.648.202.460]
        • Lactose Intolerance [C18.452.648.202.589]
        • Mannosidase Deficiency Diseases [C18.452.648.202.607]
          • alpha-Mannosidosis [C18.452.648.202.607.500]
          • beta-Mannosidosis [C18.452.648.202.607.750]
        • Mucolipidoses [C18.452.648.202.670]
        • Mucopolysaccharidoses [C18.452.648.202.715]
          • Mucopolysaccharidosis I [C18.452.648.202.715.640]
          • Mucopolysaccharidosis II [C18.452.648.202.715.645]
          • Mucopolysaccharidosis III [C18.452.648.202.715.650]
          • Mucopolysaccharidosis IV [C18.452.648.202.715.655]
          • Mucopolysaccharidosis VI [C18.452.648.202.715.670]
          • Mucopolysaccharidosis VII [C18.452.648.202.715.675]
        • Multiple Carboxylase Deficiency [C18.452.648.202.720]
          • Biotinidase Deficiency [C18.452.648.202.720.100]
          • Holocarboxylase Synthetase Deficiency [C18.452.648.202.720.380]
        • Pyruvate Metabolism, Inborn Errors [C18.452.648.202.810]
          • Leigh Disease [C18.452.648.202.810.444]
          • Pyruvate Carboxylase Deficiency Disease [C18.452.648.202.810.666]
          • Pyruvate Dehydrogenase Complex Deficiency Disease [C18.452.648.202.810.766]
      • Hyperbilirubinemia, Hereditary [C18.452.648.300]
        • Crigler-Najjar Syndrome [C18.452.648.300.281]
        • Gilbert Disease [C18.452.648.300.528]
        • Jaundice, Chronic Idiopathic [C18.452.648.300.764]
      • Lipid Metabolism, Inborn Errors [C18.452.648.398]
        • Hyperlipidemia, Familial Combined [C18.452.648.398.450]
        • Hyperlipoproteinemia Type I [C18.452.648.398.465]
        • Hyperlipoproteinemia Type II [C18.452.648.398.481]
        • Hyperlipoproteinemia Type III [C18.452.648.398.483]
        • Hyperlipoproteinemia Type IV [C18.452.648.398.487]
        • Hyperlipoproteinemia Type V [C18.452.648.398.493]
        • Hypolipoproteinemias [C18.452.648.398.500]
          • Hypoalphalipoproteinemias [C18.452.648.398.500.330]
            • Lecithin Acyltransferase Deficiency [C18.452.648.398.500.330.500]
            • Tangier Disease [C18.452.648.398.500.330.750]
          • Hypobetalipoproteinemias [C18.452.648.398.500.440]
            • Abetalipoproteinemia [C18.452.648.398.500.440.500]
        • Lipidoses [C18.452.648.398.641]
          • Cholesterol Ester Storage Disease [C18.452.648.398.641.201]
            • Wolman Disease [C18.452.648.398.641.201.500]
          • Neuronal Ceroid-Lipofuscinoses [C18.452.648.398.641.509]
          • Sjogren-Larsson Syndrome [C18.452.648.398.641.723]
          • Sphingolipidoses [C18.452.648.398.641.803]
            • Fabry Disease [C18.452.648.398.641.803.300]
            • Gangliosidoses [C18.452.648.398.641.803.350]
              • Gangliosidoses, GM2 [C18.452.648.398.641.803.350.300]
                • Sandhoff Disease [C18.452.648.398.641.803.350.300.700]
                • Tay-Sachs Disease [C18.452.648.398.641.803.350.300.850]
                • Tay-Sachs Disease, AB Variant [C18.452.648.398.641.803.350.300.925]
              • Gangliosidosis, GM1 [C18.452.648.398.641.803.350.360]
            • Gaucher Disease [C18.452.648.398.641.803.441]
            • Leukodystrophy, Globoid Cell [C18.452.648.398.641.803.585]
            • Niemann-Pick Diseases [C18.452.648.398.641.803.730]
              • Niemann-Pick Disease, Type A [C18.452.648.398.641.803.730.500]
              • Niemann-Pick Disease, Type B [C18.452.648.398.641.803.730.750]
              • Niemann-Pick Disease, Type C [C18.452.648.398.641.803.730.875]
            • Sea-Blue Histiocyte Syndrome [C18.452.648.398.641.803.850]
            • Sulfatidosis [C18.452.648.398.641.803.925]
              • Leukodystrophy, Metachromatic [C18.452.648.398.641.803.925.500]
              • Multiple Sulfatase Deficiency Disease [C18.452.648.398.641.803.925.750]
        • Smith-Lemli-Opitz Syndrome [C18.452.648.398.850]
        • Xanthomatosis, Cerebrotendinous [C18.452.648.398.925]
      • Lysosomal Storage Diseases [C18.452.648.595]
        • Cholesterol Ester Storage Disease [C18.452.648.595.201]
          • Wolman Disease [C18.452.648.595.201.500]
        • Cystinosis [C18.452.648.595.377]
        • Lysosomal Storage Diseases, Nervous System [C18.452.648.595.554]
          • Fucosidosis [C18.452.648.595.554.295]
          • Glycogen Storage Disease Type II [C18.452.648.595.554.340]
          • Mucolipidoses [C18.452.648.595.554.590]
          • Sialic Acid Storage Disease [C18.452.648.595.554.810]
          • Sphingolipidoses [C18.452.648.595.554.825]
            • Fabry Disease [C18.452.648.595.554.825.200]
            • Gangliosidoses [C18.452.648.595.554.825.300]
              • Gangliosidoses, GM2 [C18.452.648.595.554.825.300.300]
                • Sandhoff Disease [C18.452.648.595.554.825.300.300.800]
                • Tay-Sachs Disease [C18.452.648.595.554.825.300.300.840]
                • Tay-Sachs Disease, AB Variant [C18.452.648.595.554.825.300.300.920]
              • Gangliosidosis, GM1 [C18.452.648.595.554.825.300.400]
            • Gaucher Disease [C18.452.648.595.554.825.400]
            • Leukodystrophy, Globoid Cell [C18.452.648.595.554.825.590]
            • Niemann-Pick Diseases [C18.452.648.595.554.825.700]
              • Niemann-Pick Disease, Type A [C18.452.648.595.554.825.700.500]
              • Niemann-Pick Disease, Type B [C18.452.648.595.554.825.700.750]
              • Niemann-Pick Disease, Type C [C18.452.648.595.554.825.700.875]
            • Sea-Blue Histiocyte Syndrome [C18.452.648.595.554.825.775]
            • Sulfatidosis [C18.452.648.595.554.825.850]
              • Leukodystrophy, Metachromatic [C18.452.648.595.554.825.850.500]
              • Multiple Sulfatase Deficiency Disease [C18.452.648.595.554.825.850.750]
        • Mannosidase Deficiency Diseases [C18.452.648.595.577]
          • alpha-Mannosidosis [C18.452.648.595.577.500]
          • beta-Mannosidosis [C18.452.648.595.577.750]
        • Mucopolysaccharidoses [C18.452.648.595.600]
          • Mucopolysaccharidosis I [C18.452.648.595.600.640]
          • Mucopolysaccharidosis II [C18.452.648.595.600.645]
          • Mucopolysaccharidosis III [C18.452.648.595.600.650]
          • Mucopolysaccharidosis IV [C18.452.648.595.600.655]
          • Mucopolysaccharidosis VI [C18.452.648.595.600.670]
          • Mucopolysaccharidosis VII [C18.452.648.595.600.675]
      • Metal Metabolism, Inborn Errors [C18.452.648.618]
        • Hemochromatosis [C18.452.648.618.337]
        • Hepatolenticular Degeneration [C18.452.648.618.403]
        • Hypophosphatasia [C18.452.648.618.482]
        • Hypophosphatemia, Familial [C18.452.648.618.544]
          • Hypophosphatemic Rickets, X-Linked Dominant [C18.452.648.618.544.500]
        • Menkes Kinky Hair Syndrome [C18.452.648.618.590]
        • Paralyses, Familial Periodic [C18.452.648.618.711]
          • Hypokalemic Periodic Paralysis [C18.452.648.618.711.550]
          • Paralysis, Hyperkalemic Periodic [C18.452.648.618.711.600]
        • Pseudohypoparathyroidism [C18.452.648.618.815]
          • Pseudopseudohypoparathyroidism [C18.452.648.618.815.815]
      • Peroxisomal Disorders [C18.452.648.663]
        • Acatalasia [C18.452.648.663.025]
        • Adrenoleukodystrophy [C18.452.648.663.112]
        • Chondrodysplasia Punctata, Rhizomelic [C18.452.648.663.200]
        • Mevalonate Kinase Deficiency [C18.452.648.663.480]
        • Refsum Disease [C18.452.648.663.760]
        • Refsum Disease, Infantile [C18.452.648.663.865]
        • Zellweger Syndrome [C18.452.648.663.970]
      • Porphyrias [C18.452.648.708]
        • Porphyria, Erythropoietic [C18.452.648.708.250]
        • Porphyrias, Hepatic [C18.452.648.708.400]
          • Coproporphyria, Hereditary [C18.452.648.708.400.074]
          • Porphyria, Acute Intermittent [C18.452.648.708.400.150]
          • Porphyria Cutanea Tarda [C18.452.648.708.400.250]
          • Porphyria, Hepatoerythropoietic [C18.452.648.708.400.437]
          • Porphyria, Variegate [C18.452.648.708.400.625]
          • Protoporphyria, Erythropoietic [C18.452.648.708.400.812]
      • Progeria [C18.452.648.753]
      • Purine-Pyrimidine Metabolism, Inborn Errors [C18.452.648.798]
        • Dihydropyrimidine Dehydrogenase Deficiency [C18.452.648.798.183]
        • Gout [C18.452.648.798.368]
          • Arthritis, Gouty [C18.452.648.798.368.410]
        • Lesch-Nyhan Syndrome [C18.452.648.798.594]
      • Renal Tubular Transport, Inborn Errors [C18.452.648.861]
        • Acidosis, Renal Tubular [C18.452.648.861.093]
        • Fanconi Syndrome [C18.452.648.861.450]
        • Glycosuria, Renal [C18.452.648.861.532]
        • Hypophosphatemia, Familial [C18.452.648.861.647]
          • Hypophosphatemic Rickets, X-Linked Dominant [C18.452.648.861.647.500]
        • Oculocerebrorenal Syndrome [C18.452.648.861.750]
        • Pseudohypoaldosteronism [C18.452.648.861.770]
        • Renal Aminoacidurias [C18.452.648.861.885]
          • Cystinuria [C18.452.648.861.885.250]
      • Steroid Metabolism, Inborn Errors [C18.452.648.925]
        • Adrenal Hyperplasia, Congenital [C18.452.648.925.249]
        • Ichthyosis, X-Linked [C18.452.648.925.400]
        • Mineralocorticoid Excess Syndrome, Apparent [C18.452.648.925.500]
        • Smith-Lemli-Opitz Syndrome [C18.452.648.925.875]
    • Mitochondrial Diseases [C18.452.660]
      • Carbamoyl-Phosphate Synthase I Deficiency Disease [C18.452.660.097]
      • Cytochrome-c Oxidase Deficiency [C18.452.660.195]
      • Friedreich Ataxia [C18.452.660.300]
      • Leigh Disease [C18.452.660.520]
      • Mitochondrial Myopathies [C18.452.660.560]
        • Mitochondrial Encephalomyopathies [C18.452.660.560.620]
          • MELAS Syndrome [C18.452.660.560.620.520]
          • MERRF Syndrome [C18.452.660.560.620.530]
        • Ophthalmoplegia, Chronic Progressive External [C18.452.660.560.700]
          • Kearns-Sayer Syndrome [C18.452.660.560.700.500]
      • Multiple Acyl Coenzyme A Dehydrogenase Deficiency [C18.452.660.612]
      • Optic Atrophy, Autosomal Dominant [C18.452.660.665]
      • Optic Atrophy, Hereditary, Leber [C18.452.660.670]
      • Pyruvate Carboxylase Deficiency Disease [C18.452.660.705]
      • Pyruvate Dehydrogenase Complex Deficiency Disease [C18.452.660.710]
    • Phosphorus Metabolism Disorders [C18.452.750]
      • Hyperphosphatemia [C18.452.750.199]
      • Hypophosphatemia [C18.452.750.400]
        • Hypophosphatemia, Familial [C18.452.750.400.500]
    • Porphyrias [C18.452.811]
      • Porphyria, Erythropoietic [C18.452.811.250]
      • Porphyrias, Hepatic [C18.452.811.400]
        • Coproporphyria, Hereditary [C18.452.811.400.074]
        • Porphyria, Acute Intermittent [C18.452.811.400.150]
        • Porphyria Cutanea Tarda [C18.452.811.400.250]
        • Porphyria, Hepatoerythropoietic [C18.452.811.400.437]
        • Porphyria, Variegate [C18.452.811.400.625]
        • Protoporphyria, Erythropoietic [C18.452.811.400.812]
    • Skin Diseases, Metabolic [C18.452.880]
      • Lipodystrophy [C18.452.880.391]
        • HIV-Associated Lipodystrophy Syndrome [C18.452.880.391.400]
        • Lipodystrophy, Congenital Generalized [C18.452.880.391.550]
        • Lipodystrophy, Familial Partial [C18.452.880.391.700]
      • Necrobiosis Lipoidica [C18.452.880.495]
      • Porphyrias [C18.452.880.617]
        • Porphyria, Erythropoietic [C18.452.880.617.250]
        • Porphyrias, Hepatic [C18.452.880.617.400]
          • Coproporphyria, Hereditary [C18.452.880.617.400.074]
          • Porphyria, Acute Intermittent [C18.452.880.617.400.150]
          • Porphyria Cutanea Tarda [C18.452.880.617.400.250]
          • Porphyria, Hepatoerythropoietic [C18.452.880.617.400.437]
          • Porphyria, Variegate [C18.452.880.617.400.625]
          • Protoporphyria, Erythropoietic [C18.452.880.617.400.812]
    • Wasting Syndrome [C18.452.915]
      • HIV Wasting Syndrome [C18.452.915.520]
    • Water-Electrolyte Imbalance [C18.452.950]
      • Dehydration [C18.452.950.179]
      • Hypercalcemia [C18.452.950.340]
      • Hyperkalemia [C18.452.950.396]
      • Hypernatremia [C18.452.950.452]
      • Hypocalcemia [C18.452.950.509]
      • Hypokalemia [C18.452.950.565]
      • Hyponatremia [C18.452.950.620]
      • Inappropriate ADH Syndrome [C18.452.950.626]
      • Water Intoxication [C18.452.950.932]
  • Nutrition Disorders [C18.654]
    • Child Nutrition Disorders [C18.654.180]
    • Hypervitaminosis A [C18.654.301]
    • Infant Nutrition Disorders [C18.654.422]
      • Hemorrhagic Disease of Newborn [C18.654.422.360]
    • Malnutrition [C18.654.521]
      • Deficiency Diseases [C18.654.521.500]
        • Avitaminosis [C18.654.521.500.133]
          • Ascorbic Acid Deficiency [C18.654.521.500.133.115]
            • Scurvy [C18.654.521.500.133.115.661]
          • Vitamin A Deficiency [C18.654.521.500.133.628]
          • Vitamin B Deficiency [C18.654.521.500.133.699]
            • Choline Deficiency [C18.654.521.500.133.699.160]
            • Folic Acid Deficiency [C18.654.521.500.133.699.308]
            • Pellagra [C18.654.521.500.133.699.529]
            • Riboflavin Deficiency [C18.654.521.500.133.699.713]
            • Thiamine Deficiency [C18.654.521.500.133.699.827]
              • Beriberi [C18.654.521.500.133.699.827.223]
              • Wernicke Encephalopathy [C18.654.521.500.133.699.827.822]
            • Vitamin B 6 Deficiency [C18.654.521.500.133.699.901]
            • Vitamin B 12 Deficiency [C18.654.521.500.133.699.923]
              • Anemia, Pernicious [C18.654.521.500.133.699.923.280]
              • Subacute Combined Degeneration [C18.654.521.500.133.699.923.640]
          • Vitamin D Deficiency [C18.654.521.500.133.770]
            • Osteomalacia [C18.654.521.500.133.770.496]
            • Rickets [C18.654.521.500.133.770.734]
              • Hypophosphatemic Rickets, X-Linked Dominant [C18.654.521.500.133.770.734.500]
              • Renal Osteodystrophy [C18.654.521.500.133.770.734.750]
          • Vitamin E Deficiency [C18.654.521.500.133.841]
            • Steatitis [C18.654.521.500.133.841.682]
          • Vitamin K Deficiency [C18.654.521.500.133.912]
            • Hemorrhagic Disease of Newborn [C18.654.521.500.133.912.360]
        • Magnesium Deficiency [C18.654.521.500.439]
        • Potassium Deficiency [C18.654.521.500.617]
        • Protein Deficiency [C18.654.521.500.708]
          • Protein-Energy Malnutrition [C18.654.521.500.708.626]
            • Kwashiorkor [C18.654.521.500.708.626.505]
        • Swayback [C18.654.521.500.857]
      • Fetal Nutrition Disorders [C18.654.521.625]
      • Starvation [C18.654.521.750]
    • Overnutrition [C18.654.726]
      • Obesity [C18.654.726.500]
        • Obesity Hypoventilation Syndrome [C18.654.726.500.695]
        • Obesity, Morbid [C18.654.726.500.700]
        • Prader-Willi Syndrome [C18.654.726.500.740]
    • Wasting Syndrome [C18.654.940]
      • HIV Wasting Syndrome [C18.654.940.520]

Copyright, Privacy, Accessibility, Site Map, Viewers and Players
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act, Contact Us

Last updated: 07 October 2007
First published: 07 October 2007
Metadata| Permanence level: Permanent: Dynamic Content